Literature DB >> 14760933

Influence of ionic and non-ionic radiographic contrast media on leukocyte adhesion molecules.

Guy L J Vermeiren1, Roel Willems, Marc J Claeys, Chris Vrints, Herman Slegers, Philippe G Jorens.   

Abstract

BACKGROUND: Many papers have focused on the importance of granulocytes in the process of reperfusion and ischemia. Most of the clinical studies measured several parameters of this process during and after coronary angiography, without taking into account the effect of the radiographic contrast media (RCM) used during this procedure.
MATERIALS AND METHODS: We performed a randomized patient study (n = 37) to evaluate the effect of ionic and non-ionic RCM on granulocyte adhesion during coronary angiography. We also evaluated the influence of the ionicity and osmolarity of the different substances on granulocyte adhesion molecules in in vitro experiments.
RESULTS: The osmolarity of patient serum samples increased from 302 +/- 1 to 309 +/- 1 mOsm/kg (p < 0.05) after infusion of RCM. The CD11b expression in the samples of the non-ionic RCM treated group increased from 221 +/- 21 MFI to 377 +/- 30 MFI (p < 0.05) measured as the absolute mean fluorescence intensity (MFI), yet did not alter significantly in the ionic RCM group. In contrast, the in vitro experiments showed a reduction of the CD11b expression from 360 +/- 70 MFI to 149 +/- 30 MFI (p < 0.05) in the ionic RCM group.
CONCLUSIONS: The upregulation of adhesion molecules was significantly reduced in vivo with ionic RCM, while ionic substances caused opposite effects in vitro. This effect should be taken into account when performing leukocyte functional analysis of samples taken during angiography.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14760933      PMCID: PMC1781624          DOI: 10.1080/09629350310001619690

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  42 in total

Review 1.  Reperfusion injury after focal myocardial ischaemia: polymorphonuclear leukocyte activation and its clinical implications.

Authors:  G L Vermeiren; M J Claeys; D Van Bockstaele; B Grobben; H Slegers; L Bossaert; P G Jorens
Journal:  Resuscitation       Date:  2000-06       Impact factor: 5.262

2.  Activation of complement by radiographic contrast media: generation of chemotactic and anaphylatoxin activities.

Authors:  G Till; U Rother; D Gemsa
Journal:  Int Arch Allergy Appl Immunol       Date:  1978

3.  Emergency treatment of anaphylactoid reactions to radiographic contrast materials.

Authors:  P G Mueller
Journal:  Md Med J       Date:  1985-03

4.  Effects of radiographic contrast media on leukocyte locomotion.

Authors:  D H Carr; A C Walker; R G White
Journal:  Invest Radiol       Date:  1981 Mar-Apr       Impact factor: 6.016

5.  Anaphylaxis following "Hexabrix" during routine coronary angiography.

Authors:  J A Langton; P Magee; J Sedgwick; R Sutton
Journal:  Eur J Radiol       Date:  1988-02       Impact factor: 3.528

6.  Prevention of anaphylactoid reactions after radiographic contrast media infusion by combined histamine H1- and H2-receptor antagonists: results of a prospective controlled trial.

Authors:  J Ring; K H Rothenberger; W Clauss
Journal:  Int Arch Allergy Appl Immunol       Date:  1985

Review 7.  Role of selectins in myocardial ischemia-reperfusion injury.

Authors:  A M Lefer
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

Review 8.  Leukocytes and the risk of ischemic diseases.

Authors:  E Ernst; D E Hammerschmidt; U Bagge; A Matrai; J A Dormandy
Journal:  JAMA       Date:  1987-05-01       Impact factor: 56.272

9.  Sites of cerebrovascular injury induced by radiographic contrast media.

Authors:  R L Casady; G T Kitten; I M Bradley; P R Sterrett
Journal:  Am J Anat       Date:  1978-11

10.  Effects of intravenous radiographic contrast media on the blood pressure and on factors of the contact activation system in the rat.

Authors:  N O Hoem; G Briseid; S Ekelund; S Salvesen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1986-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.